Stroke and LDL cholesterol
Links shared publicly online about this topic.
- 2,112total visits
Stroke and LDL cholesterol
View full resource at theheart.org
Tags: Cholesterol, Stroke, Thrombotic Event
Most Recently Shared on April 16, 2009 at 2:05 pm By:
heartwire: Reducing LDL cholesterol with statins reduces stroke risk: meta-analysis http://tinyurl.com/ccekbg
04-03-2012 - 5 Ways to Lower your Cholesterol Naturally
archive.aweber.com — “04-03-2012 - 5 Ways to Lower your Cholesterol Naturally” View full resource at archive.aweber.com
Most Recently Shared on April 4, 2012 at 1:49 am By:
Dr. John Dempster CAM, Naturopathic Doctor, Active Health Library, and Acupuncturist
5 Ways to Lower Your Cholesterol levels Naturally http://t.co/RALKvVZE #heartdisease #stroke
Statins Alter Predictive Value of LDL (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Among patients taking statins, on-treatment levels of non-high-density lipoprotein (non-HDL) cholesterol may be best for predicting future cardiovascular events, according to a meta-analysis.?” View full resource at qualitypointtech.net
Most Recently Shared on March 29, 2012 at 12:00 am By:
Statins Alter Predictive Value of LDL (CME/CE): (MedPage Today) -- Among patients taking statins, on-treatment lev... http://t.co/GHysczJk
Cholesterol Shot: Monthly Injection Can Lower LDL Levels By 66 Percent, New Study Claims - International Business Times
ibtimes.com — “A monthly cholesterol shot can reduce patients' levels by up to 66 percent, according to a new study described at a U.S. cardiology conference.” View full resource at ibtimes.com
Most Recently Shared on March 27, 2012 at 8:11 pm By:
Cholesterol Shot: Monthly Injection Can Lower LDL Levels By 66 Percent, New Study Claims: A monthly cholesterol ... http://t.co/bwTcXDyb
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 27, 2012 at 1:12 am By:
James Underberg Doctor, Internist, and Physician
New monoclonal antibody to #PCSK9 impresses with #LDL-cholesterol reductions http://t.co/wyBklTA3
ACC: Biologic Wows for Lipid Lowering (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “CHICAGO (MedPage Today) -- A novel monoclonal antibody when added to statin therapy substantially cuts LDL cholesterol levels beyond reductions achieved with statin therapy alone, a phase II study found.” View full resource at qualitypointtech.net
Most Recently Shared on March 27, 2012 at 1:00 am By:
ACC: Biologic Wows for Lipid Lowering (CME/CE): CHICAGO (MedPage Today) -- A novel monoclonal antibody when added ... http://t.co/cOPzpZtL
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 26, 2012 at 9:57 pm By:
New monoclonal antibody to PCSK9 impresses with LDL-cholesterol reductions http://t.co/SJNDXAQR #ACC12
Sanofi-Regeneron drug lowers cholesterol up to 72 percent in study - The Boston Globe online
boston.com — “An experimental drug from Sanofi and Regeneron Pharmaceuticals Inc. lowered patients’ so-called bad cholesterol by as much as 72 percent on top of Lipitor in a company-funded study. (Last year, French drug maker Sanofi bought Genzyme Corp. of Cambridge for $20.1 billion.) The medicine, one in a class of drugs targeting the PCSK9 gene, reduced patients’ average LDL cholesterol levels to as little as 34 milligrams per deciliter after 12 weeks in the mid- stage study.” View full resource at boston.com
Most Recently Shared on March 26, 2012 at 8:07 pm By:
Sanofi-Regeneron drug lowers cholesterol up to 72 percent in study: An experimental drug from Sanofi and Regener... http://t.co/IPHjtIv5
New Cholesterol-Lowering Drugs Will Test the Future Healthcare System - Forbes
forbes.com — “The American College of Cardiology (ACC) meeting is in full swing this week in Chicago and much of the early buzz being generated is around a new class of LDL cholesterol-lowering drugs known as proprotein converase subtilisin/kexin type 9 (PCSK-9) antibodies. Inhibitors of PCSK-9 have been pursued for almost a [...]” View full resource at forbes.com
Most Recently Shared on March 26, 2012 at 8:07 pm By:
New Cholesterol-Lowering Drugs Will Test the Future Healthcare System: The American College of Cardiology (ACC) ... http://t.co/p51Irjyi
New Cholesterol-Lowering Drugs Will Test the Future Healthcare System - Forbes
forbes.com — “The American College of Cardiology (ACC) meeting is in full swing this week in Chicago and much of the early buzz being generated is around a new class of LDL cholesterol-lowering drugs known as proprotein converase subtilisin/kexin type 9 (PCSK-9) antibodies. Inhibitors of PCSK-9 have been pursued for almost a [...]” View full resource at forbes.com
Most Recently Shared on March 26, 2012 at 5:52 pm By:
Drugs and Devices OW OW Health
New Cholesterol-Lowering Drugs Will Test the Future Healthcare System: The American College of Cardiology ... http://t.co/YvG6SI3g #drug
Low LDL cholesterol is related to cancer risk http://t.co/52zUtQCS
snsanalytics.com — “Low LDL cholesterol is related to cancer risk http://t.co/52zUtQCS” View full resource at snsanalytics.com
Most Recently Shared on March 26, 2012 at 5:21 pm By:
Cancer News Network Health News
Low LDL cholesterol is related to cancer risk http://t.co/52zUtQCS
Regeneron cholesterol drug faces sudden challenge - Yahoo! News
news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - A new type of drug being developed by Regeneron Pharmaceuticals Inc slashed levels of cholesterol almost in half when given every four weeks, but fell short of reductions reported a day earlier with once-monthly injections of Amgen Inc's rival product. Both monoclonal antibodies work by blocking a protein called PCSK9, and are shaping up to be the next big thing in preventing heart attack and stroke. ...” View full resource at news.yahoo.com
Most Recently Shared on March 26, 2012 at 4:49 pm By:
HealthTrendster Health Executive
Regeneron cholesterol drug faces sudden challenge - CHICAGO (Reuters) - A new type of drug being developed by Regene... http://t.co/RNIiOuO7
Lowering LDL, the earlier the better
medicalxpress.com — “Coronary atherosclerosis – a hardening of the arteries due to a build-up of fat and cholesterol – can lead to heart attacks and other forms of coronary heart disease (CHD). Lowering low-density lipoprotein (LDL), or 'bad' cholesterol, reduces the risk of CHD, and researchers found that lowering ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 4:40 pm By:
PhysOrg Health News Health News
Lowering LDL, the earlier the better http://t.co/3fKO13vx
Antibody injection lowers LDL, adding to effectiveness of statin therapy
medicalxpress.com — “A novel monoclonal antibody identified in a new study dramatically lowered circulating LDL cholesterol by 40 percent to 72 percent, a development with potential to provide a new option for patients who are resistant to cholesterol-lowering drugs such as statins or to the current standard of care, according ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 4:37 pm By:
PhysOrg Health News Health News
Antibody injection lowers LDL, adding to effectiveness of statin therapy http://t.co/6ObXB59K
Low LDL cholesterol is related to cancer risk
eurekalert.org — “Low LDL cholesterol in patients with no history of taking cholesterol-lowering drugs predates cancer risk by decades, suggesting there may be some underlying mechanism affecting both cancer and low LDL cholesterol that requires further examination, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the f” View full resource at eurekalert.org
Most Recently Shared on March 26, 2012 at 2:06 pm By:
Low LDL cholesterol is related to cancer risk: Low LDL cholesterol in patients with no history of taking cholest... http://t.co/RyRu6e0b
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - MarketWatch
marketwatch.com — “Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on March 26, 2012 at 12:15 pm By:
Cary Byrd - eDrugSearch.com Pharma and Health Advocate
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - MarketWatch http://t.co/JegMV1XV
Advertisement
